Electroconvulsive therapy increases temporarily plasma vascular endothelial growth factor in patients with major depressive disorder

Abstract Objectives Vascular endothelial growth factor (VEGF) has been related to the etiology of major depressive disorder (MDD). The findings involving the effects of electroconvulsive therapy (ECT) on the VEGF levels have been conflicting. The aim was to examine the possible changes in the VEGF l...

Full description

Bibliographic Details
Main Authors: Annamari Sorri, Kaija Järventausta, Olli Kampman, Kai Lehtimäki, Minna Björkqvist, Kati Tuohimaa, Mari Hämäläinen, Eeva Moilanen, Esa Leinonen
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:Brain and Behavior
Subjects:
Online Access:https://doi.org/10.1002/brb3.2001
_version_ 1797754646481076224
author Annamari Sorri
Kaija Järventausta
Olli Kampman
Kai Lehtimäki
Minna Björkqvist
Kati Tuohimaa
Mari Hämäläinen
Eeva Moilanen
Esa Leinonen
author_facet Annamari Sorri
Kaija Järventausta
Olli Kampman
Kai Lehtimäki
Minna Björkqvist
Kati Tuohimaa
Mari Hämäläinen
Eeva Moilanen
Esa Leinonen
author_sort Annamari Sorri
collection DOAJ
description Abstract Objectives Vascular endothelial growth factor (VEGF) has been related to the etiology of major depressive disorder (MDD). The findings involving the effects of electroconvulsive therapy (ECT) on the VEGF levels have been conflicting. The aim was to examine the possible changes in the VEGF levels and their associations with clinical outcome in patients with MDD during ECT. Methods The study comprised 30 patients suffering from MDD. Their plasma VEGF levels were measured at baseline and 2 and 4 hr after the first, fifth, and last ECT session. The severity of depression was quantified by the Montgomery‐Asberg Depression Rating Scale (MADRS). Results The VEGF levels increased between the 2‐hr and 4‐hr measurements during the first (p = .003) and the fifth (p = .017) sessions. The baseline VEGF levels between individual ECT sessions remained unchanged during the ECT series. No correlations were found between the increased VEGF levels and the clinical outcome. Conclusions Electroconvulsive therapy increased the VEGF levels repeatedly at the same time point in two different ECT sessions. These increases had no association with the response to ECT. Consequently, VEGF may act as a mediator in the mechanism of action of ECT.
first_indexed 2024-03-12T17:36:33Z
format Article
id doaj.art-47f248e4a97f4f16b3048633e66e4663
institution Directory Open Access Journal
issn 2162-3279
language English
last_indexed 2024-03-12T17:36:33Z
publishDate 2021-08-01
publisher Wiley
record_format Article
series Brain and Behavior
spelling doaj.art-47f248e4a97f4f16b3048633e66e46632023-08-04T10:56:25ZengWileyBrain and Behavior2162-32792021-08-01118n/an/a10.1002/brb3.2001Electroconvulsive therapy increases temporarily plasma vascular endothelial growth factor in patients with major depressive disorderAnnamari Sorri0Kaija Järventausta1Olli Kampman2Kai Lehtimäki3Minna Björkqvist4Kati Tuohimaa5Mari Hämäläinen6Eeva Moilanen7Esa Leinonen8Department of Psychiatry Tampere University Hospital Tampere FinlandDepartment of Psychiatry Tampere University Hospital Tampere FinlandDepartment of Psychiatry Tampere University Hospital Tampere FinlandDepartment of Neurosurgery, Neurology and Rehabilitation Tampere University Hospital Tampere FinlandDepartment of Psychiatry Tampere University Hospital Tampere FinlandDepartment of Psychiatry Tampere University Hospital Tampere FinlandThe Immunopharmacology Research Group Faculty of Medicine and Health Technology Tampere University and Tampere University Hospital Tampere FinlandThe Immunopharmacology Research Group Faculty of Medicine and Health Technology Tampere University and Tampere University Hospital Tampere FinlandDepartment of Psychiatry Tampere University Hospital Tampere FinlandAbstract Objectives Vascular endothelial growth factor (VEGF) has been related to the etiology of major depressive disorder (MDD). The findings involving the effects of electroconvulsive therapy (ECT) on the VEGF levels have been conflicting. The aim was to examine the possible changes in the VEGF levels and their associations with clinical outcome in patients with MDD during ECT. Methods The study comprised 30 patients suffering from MDD. Their plasma VEGF levels were measured at baseline and 2 and 4 hr after the first, fifth, and last ECT session. The severity of depression was quantified by the Montgomery‐Asberg Depression Rating Scale (MADRS). Results The VEGF levels increased between the 2‐hr and 4‐hr measurements during the first (p = .003) and the fifth (p = .017) sessions. The baseline VEGF levels between individual ECT sessions remained unchanged during the ECT series. No correlations were found between the increased VEGF levels and the clinical outcome. Conclusions Electroconvulsive therapy increased the VEGF levels repeatedly at the same time point in two different ECT sessions. These increases had no association with the response to ECT. Consequently, VEGF may act as a mediator in the mechanism of action of ECT.https://doi.org/10.1002/brb3.2001electroconvulsive therapymajor depressive disordervascular endothelial growth factor
spellingShingle Annamari Sorri
Kaija Järventausta
Olli Kampman
Kai Lehtimäki
Minna Björkqvist
Kati Tuohimaa
Mari Hämäläinen
Eeva Moilanen
Esa Leinonen
Electroconvulsive therapy increases temporarily plasma vascular endothelial growth factor in patients with major depressive disorder
Brain and Behavior
electroconvulsive therapy
major depressive disorder
vascular endothelial growth factor
title Electroconvulsive therapy increases temporarily plasma vascular endothelial growth factor in patients with major depressive disorder
title_full Electroconvulsive therapy increases temporarily plasma vascular endothelial growth factor in patients with major depressive disorder
title_fullStr Electroconvulsive therapy increases temporarily plasma vascular endothelial growth factor in patients with major depressive disorder
title_full_unstemmed Electroconvulsive therapy increases temporarily plasma vascular endothelial growth factor in patients with major depressive disorder
title_short Electroconvulsive therapy increases temporarily plasma vascular endothelial growth factor in patients with major depressive disorder
title_sort electroconvulsive therapy increases temporarily plasma vascular endothelial growth factor in patients with major depressive disorder
topic electroconvulsive therapy
major depressive disorder
vascular endothelial growth factor
url https://doi.org/10.1002/brb3.2001
work_keys_str_mv AT annamarisorri electroconvulsivetherapyincreasestemporarilyplasmavascularendothelialgrowthfactorinpatientswithmajordepressivedisorder
AT kaijajarventausta electroconvulsivetherapyincreasestemporarilyplasmavascularendothelialgrowthfactorinpatientswithmajordepressivedisorder
AT ollikampman electroconvulsivetherapyincreasestemporarilyplasmavascularendothelialgrowthfactorinpatientswithmajordepressivedisorder
AT kailehtimaki electroconvulsivetherapyincreasestemporarilyplasmavascularendothelialgrowthfactorinpatientswithmajordepressivedisorder
AT minnabjorkqvist electroconvulsivetherapyincreasestemporarilyplasmavascularendothelialgrowthfactorinpatientswithmajordepressivedisorder
AT katituohimaa electroconvulsivetherapyincreasestemporarilyplasmavascularendothelialgrowthfactorinpatientswithmajordepressivedisorder
AT marihamalainen electroconvulsivetherapyincreasestemporarilyplasmavascularendothelialgrowthfactorinpatientswithmajordepressivedisorder
AT eevamoilanen electroconvulsivetherapyincreasestemporarilyplasmavascularendothelialgrowthfactorinpatientswithmajordepressivedisorder
AT esaleinonen electroconvulsivetherapyincreasestemporarilyplasmavascularendothelialgrowthfactorinpatientswithmajordepressivedisorder